Gianni De Fabritiis @gdefabritiis.bsky.social · 10/09/2026We use 1B tokens/day at Acellera, including input and cached tokens, so I’m curious how far local models can go. I tested 7 LLM + harness combinations on an IL-23 discovery task. A few surprises, including what one RTX 5090 could produce. Blog and docs: www.acellera.com/blog/beyond-... 010
Gianni De Fabritiis @gdefabritiis.bsky.social · 22/10/2025Preprint release 😀 of "Speak to a Protein," an AI co-scientist that facilitates data gathering and analysis in an interactive collaborative session. It is quite amazing to use. Preprint: arxiv.org/abs/2510.17826 094
Gianni De Fabritiis @gdefabritiis.bsky.social · 07/05/2025Check out AceFF 1.1 huggingface.co/Acellera/Ace...huggingface.coAcellera/AceFF-1.1 · Hugging FaceWe’re on a journey to advance and democratize artificial intelligence through open source and open science. 031
Gianni De Fabritiis @gdefabritiis.bsky.social · 05/05/2025Heading to Boston for the free energy workshop... www.feworkshop.orgfeworkshop.org2025 Workshop on Free Energy Methods in Drug Design 030
Reposted by Gianni De FabritiisPlayMolecule @playmolecule.com · 31/03/2025📂 Stay organized while exploring molecules in open.playmolecule.com! Group them by clicking the Group button in the menu bar. Toggle the visibility of all systems in a group by clicking on it. Watch the video to see how grouping simplifies your molecular exploration! 041
Reposted by Gianni De FabritiisPlayMolecule @playmolecule.com · 12/03/2025🐍 Dive into molecule analysis with our Python terminal in open.playmolecule.com! Interact with loaded molecules using #Moleculekit. Execute Python code within the terminal to obtain information of your systems, apply filters, perform calculations, and more. Watch the demo! 051
Gianni De Fabritiis @gdefabritiis.bsky.social · 29/01/2025I am really happy to announce our collaboration between Acellera Therapeutics and Psivant Therapeutics to push the frontiers of AI-driven drug discovery! www.linkedin.com/posts/gdefab...linkedin.comGianni De Fabritiis on LinkedIn: #ai #molecularreasoning #quantumchemistry #drugdiscoveryI am really happy to announce our collaboration between Acellera Therapeutics and Psivant Therapeutics to push the frontiers of AI-driven drug discovery!… 090
Gianni De Fabritiis @gdefabritiis.bsky.social · 21/01/2025Interested in reasoning agents? t.co/Ax9RtOLDCG @andrew.diffuse.one 0112
Gianni De Fabritiis @gdefabritiis.bsky.social · 07/01/2025Aceforce 1.0 is out and downloadable from Huggingface. It covers all interesting elements and charged molecules. Tested for relative binding affinity calculations. Just version 1.0, more to come. www.businesswire.com/news/home/20...businesswire.comAcellera Therapeutics Unveils AceForce 1.0: A Novel Family of Next-Generation Neural Network Potential Accelerating Drug DiscoveryAcellera Therapeutics, a pioneer in computational chemistry and AI-driven drug discovery, today announced the launch of AceForce 1.0, its groundbreaki 0153
Gianni De Fabritiis @gdefabritiis.bsky.social · 09/12/2024BricksRL at Neurips. I am not going this year, but don't miss our spotlight paper/poster on RL with Lego for robotics. 030
Reposted by Gianni De FabritiisFrank Noe @franknoe.bsky.social · 06/12/2024Super excited to preprint our work on developing a Biomolecular Emulator (BioEmu): Scalable emulation of protein equilibrium ensembles with generative deep learning from @msftresearch.bsky.social ch AI for Science. www.biorxiv.org/content/10.1... 21441147
Gianni De Fabritiis @gdefabritiis.bsky.social · 04/12/2024ACEMD v4 is out with the integration of neural network potentials. More to come soon. 040
Gianni De Fabritiis @gdefabritiis.bsky.social · 26/11/2024I liked part I. Let's read part II. arxiv.org/abs/2411.16489arxiv.orgO1 Replication Journey -- Part 2: Surpassing O1-preview through Simple Distillation, Big Progress or Bitter Lesson?This paper presents a critical examination of current approaches to replicating OpenAI's O1 model capabilities, with particular focus on the widespread but often undisclosed use of knowledge distillat... 050
Reposted by Gianni De FabritiisMark Riedl @markriedl.bsky.social · 22/11/2024Alibaba has their own version on GPT-o1. This might be the best description of “o1-type”systems so far arxiv.org/abs/2411.14405arxiv.orgMarco-o1: Towards Open Reasoning Models for Open-Ended SolutionsCurrently OpenAI o1 has sparked a surge of interest in the study of large reasoning models (LRM). Building on this momentum, Marco-o1 not only focuses on disciplines with standard answers, such as mat... 826739
Gianni De Fabritiis @gdefabritiis.bsky.social · 19/11/2024AMARO: All Heavy-Atom Transferable Neural Network Potentials of Protein Thermodynamics A novel machine-learning-based force field for protein thermodynamics. It uses an all-heavy-atom approach without hydrogens to simplify simulations while maintaining key dynamics. pubs.acs.org/doi/10.1021/... 38417
Reposted by Gianni De FabritiisWillie Neiswanger @willieneis.bsky.social · 10/11/2024I'm making a list of AI for Science researchers on bluesky — let me know if I missed you / if you'd like to join! go.bsky.app/AcP9Lix 16225389
Reposted by Gianni De FabritiisMark Riedl @markriedl.bsky.social · 18/11/2024Raw Story's lawsuit against OpenAI for training on their news stories was dismissed by NYC court. Court said Raw Story didn't have standing because they couldn't prove injury venturebeat.com/ai/openais-d...venturebeat.comOpenAI’s data scraping wins big as Raw Story’s copyright lawsuit dismissed by NY courtThe dismissal of Raw Story’s lawsuit is more than a win for OpenAI—it’s an indicator of how courts may handle similar copyright claims. 33912
Reposted by Gianni De FabritiisMarwin Segler @marwinsegler.bsky.social · 12/11/2024go.bsky.app/Qc4frbt Made a starter pack for computational chemists, let me know who I missed please @jchodera.bsky.social @olexandr.bsky.social @jelfschem.bsky.social 10814559